Limits...
Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual Report.

Pippias M, Stel VS, Abad Diez JM, Afentakis N, Herrero-Calvo JA, Arias M, Tomilina N, Bouzas Caamaño E, Buturovic-Ponikvar J, Čala S, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Alonso de la Torre R, García Bazaga Mde L, De Meester J, Díaz JM, Djukanovic L, Ferrer Alamar M, Finne P, Garneata L, Golan E, González Fernández R, Gutiérrez Avila G, Heaf J, Hoitsma A, Kantaria N, Kolesnyk M, Kramar R, Kramer A, Lassalle M, Leivestad T, Lopot F, Macário F, Magaz A, Martín-Escobar E, Metcalfe W, Noordzij M, Palsson R, Pechter Ü, Prütz KG, Ratkovic M, Resić H, Rutkowski B, Santiuste de Pablos C, Spustová V, Süleymanlar G, Van Stralen K, Thereska N, Wanner C, Jager KJ - Clin Kidney J (2015)

Bottom Line: The proportion of prevalent patients ≥75 years varied from 11 to 32% between countries.The overall renal transplantation rate in 2012 was 28.3 pmp (n = 15 673), with the highest rate seen in the Spanish region of Catalonia.Five-year adjusted survival for all RRT patients was 59.7% (95% confidence interval, CI: 59.3-60.0) which fell to 39.3% (95% CI: 38.7-39.9) in patients 65-74 years and 21.3% (95% CI: 20.8-21.9) in patients ≥75 years.

View Article: PubMed Central - PubMed

Affiliation: ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, Universiteit van Amsterdam , Amsterdam , the Netherlands.

ABSTRACT

Background: This article summarizes the 2012 European Renal Association-European Dialysis and Transplant Association Registry Annual Report (available at www.era-edta-reg.org) with a specific focus on older patients (defined as ≥65 years).

Methods: Data provided by 45 national or regional renal registries in 30 countries in Europe and bordering the Mediterranean Sea were used. Individual patient level data were received from 31 renal registries, whereas 14 renal registries contributed data in an aggregated form. The incidence, prevalence and survival probabilities of patients with end-stage renal disease (ESRD) receiving renal replacement therapy (RRT) and renal transplantation rates for 2012 are presented.

Results: In 2012, the overall unadjusted incidence rate of patients with ESRD receiving RRT was 109.6 per million population (pmp) (n = 69 035), ranging from 219.9 pmp in Portugal to 24.2 pmp in Montenegro. The proportion of incident patients ≥75 years varied from 15 to 44% between countries. The overall unadjusted prevalence on 31 December 2012 was 716.7 pmp (n = 451 270), ranging from 1670.2 pmp in Portugal to 146.7 pmp in the Ukraine. The proportion of prevalent patients ≥75 years varied from 11 to 32% between countries. The overall renal transplantation rate in 2012 was 28.3 pmp (n = 15 673), with the highest rate seen in the Spanish region of Catalonia. The proportion of patients ≥65 years receiving a transplant ranged from 0 to 35%. Five-year adjusted survival for all RRT patients was 59.7% (95% confidence interval, CI: 59.3-60.0) which fell to 39.3% (95% CI: 38.7-39.9) in patients 65-74 years and 21.3% (95% CI: 20.8-21.9) in patients ≥75 years.

No MeSH data available.


Related in: MedlinePlus

(A) The unadjusted incidence of ESRD patients on RRT, pmp on Day 1, among all national and regional renal registries in 30 countries reporting to the ERA-EDTA Registry in 2012. The incidence data for Czech Republic and Slovakia include dialysis patients only. Dutch- and French-speaking Belgium, the Spanish regions of Cantabria, Castile and León and Castile-La Mancha and the UK; England, Northern Ireland and Wales do not report on patients younger than 20 years. (B) The unadjusted incidence of ESRD patients aged 75 years and older on RRT, per million age-related population (pmarp) at Day 1, among all national and regional renal registries in 17 countries providing individual level data to the ERA-EDTA Registry in 2012. B&H: Bosnia–Herzegovina; ME: Montenegro.
© Copyright Policy - creative-commons
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4440462&req=5

SFV014F1: (A) The unadjusted incidence of ESRD patients on RRT, pmp on Day 1, among all national and regional renal registries in 30 countries reporting to the ERA-EDTA Registry in 2012. The incidence data for Czech Republic and Slovakia include dialysis patients only. Dutch- and French-speaking Belgium, the Spanish regions of Cantabria, Castile and León and Castile-La Mancha and the UK; England, Northern Ireland and Wales do not report on patients younger than 20 years. (B) The unadjusted incidence of ESRD patients aged 75 years and older on RRT, per million age-related population (pmarp) at Day 1, among all national and regional renal registries in 17 countries providing individual level data to the ERA-EDTA Registry in 2012. B&H: Bosnia–Herzegovina; ME: Montenegro.

Mentions: In 2014, the ERA-EDTA Registry received the 2012 data from the national and regional renal registries in 30 countries in Europe and those bordering the Mediterranean Sea (Figure 1A). Data sets with individual patient data were received from 31 national or regional renal registries in 17 countries, whereas 14 national renal registries contributed data in an aggregated form. The percentage coverage of the general population by the renal registries was >98% for all participating countries with the exception of Romania (96%), Latvia (85%) and Georgia (63.5%). The total coverage of the European population by the ERA-EDTA Registry in 2012 was 71.3%. A list of the European countries with available data and those without is provided in Appendix 1.Fig. 1.


Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual Report.

Pippias M, Stel VS, Abad Diez JM, Afentakis N, Herrero-Calvo JA, Arias M, Tomilina N, Bouzas Caamaño E, Buturovic-Ponikvar J, Čala S, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Alonso de la Torre R, García Bazaga Mde L, De Meester J, Díaz JM, Djukanovic L, Ferrer Alamar M, Finne P, Garneata L, Golan E, González Fernández R, Gutiérrez Avila G, Heaf J, Hoitsma A, Kantaria N, Kolesnyk M, Kramar R, Kramer A, Lassalle M, Leivestad T, Lopot F, Macário F, Magaz A, Martín-Escobar E, Metcalfe W, Noordzij M, Palsson R, Pechter Ü, Prütz KG, Ratkovic M, Resić H, Rutkowski B, Santiuste de Pablos C, Spustová V, Süleymanlar G, Van Stralen K, Thereska N, Wanner C, Jager KJ - Clin Kidney J (2015)

(A) The unadjusted incidence of ESRD patients on RRT, pmp on Day 1, among all national and regional renal registries in 30 countries reporting to the ERA-EDTA Registry in 2012. The incidence data for Czech Republic and Slovakia include dialysis patients only. Dutch- and French-speaking Belgium, the Spanish regions of Cantabria, Castile and León and Castile-La Mancha and the UK; England, Northern Ireland and Wales do not report on patients younger than 20 years. (B) The unadjusted incidence of ESRD patients aged 75 years and older on RRT, per million age-related population (pmarp) at Day 1, among all national and regional renal registries in 17 countries providing individual level data to the ERA-EDTA Registry in 2012. B&H: Bosnia–Herzegovina; ME: Montenegro.
© Copyright Policy - creative-commons
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4440462&req=5

SFV014F1: (A) The unadjusted incidence of ESRD patients on RRT, pmp on Day 1, among all national and regional renal registries in 30 countries reporting to the ERA-EDTA Registry in 2012. The incidence data for Czech Republic and Slovakia include dialysis patients only. Dutch- and French-speaking Belgium, the Spanish regions of Cantabria, Castile and León and Castile-La Mancha and the UK; England, Northern Ireland and Wales do not report on patients younger than 20 years. (B) The unadjusted incidence of ESRD patients aged 75 years and older on RRT, per million age-related population (pmarp) at Day 1, among all national and regional renal registries in 17 countries providing individual level data to the ERA-EDTA Registry in 2012. B&H: Bosnia–Herzegovina; ME: Montenegro.
Mentions: In 2014, the ERA-EDTA Registry received the 2012 data from the national and regional renal registries in 30 countries in Europe and those bordering the Mediterranean Sea (Figure 1A). Data sets with individual patient data were received from 31 national or regional renal registries in 17 countries, whereas 14 national renal registries contributed data in an aggregated form. The percentage coverage of the general population by the renal registries was >98% for all participating countries with the exception of Romania (96%), Latvia (85%) and Georgia (63.5%). The total coverage of the European population by the ERA-EDTA Registry in 2012 was 71.3%. A list of the European countries with available data and those without is provided in Appendix 1.Fig. 1.

Bottom Line: The proportion of prevalent patients ≥75 years varied from 11 to 32% between countries.The overall renal transplantation rate in 2012 was 28.3 pmp (n = 15 673), with the highest rate seen in the Spanish region of Catalonia.Five-year adjusted survival for all RRT patients was 59.7% (95% confidence interval, CI: 59.3-60.0) which fell to 39.3% (95% CI: 38.7-39.9) in patients 65-74 years and 21.3% (95% CI: 20.8-21.9) in patients ≥75 years.

View Article: PubMed Central - PubMed

Affiliation: ERA-EDTA Registry, Department of Medical Informatics, Academic Medical Center, Universiteit van Amsterdam , Amsterdam , the Netherlands.

ABSTRACT

Background: This article summarizes the 2012 European Renal Association-European Dialysis and Transplant Association Registry Annual Report (available at www.era-edta-reg.org) with a specific focus on older patients (defined as ≥65 years).

Methods: Data provided by 45 national or regional renal registries in 30 countries in Europe and bordering the Mediterranean Sea were used. Individual patient level data were received from 31 renal registries, whereas 14 renal registries contributed data in an aggregated form. The incidence, prevalence and survival probabilities of patients with end-stage renal disease (ESRD) receiving renal replacement therapy (RRT) and renal transplantation rates for 2012 are presented.

Results: In 2012, the overall unadjusted incidence rate of patients with ESRD receiving RRT was 109.6 per million population (pmp) (n = 69 035), ranging from 219.9 pmp in Portugal to 24.2 pmp in Montenegro. The proportion of incident patients ≥75 years varied from 15 to 44% between countries. The overall unadjusted prevalence on 31 December 2012 was 716.7 pmp (n = 451 270), ranging from 1670.2 pmp in Portugal to 146.7 pmp in the Ukraine. The proportion of prevalent patients ≥75 years varied from 11 to 32% between countries. The overall renal transplantation rate in 2012 was 28.3 pmp (n = 15 673), with the highest rate seen in the Spanish region of Catalonia. The proportion of patients ≥65 years receiving a transplant ranged from 0 to 35%. Five-year adjusted survival for all RRT patients was 59.7% (95% confidence interval, CI: 59.3-60.0) which fell to 39.3% (95% CI: 38.7-39.9) in patients 65-74 years and 21.3% (95% CI: 20.8-21.9) in patients ≥75 years.

No MeSH data available.


Related in: MedlinePlus